New

Continuous Glucose Monitoring Market

2021

Continuous Glucose Monitoring Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Sensors, Transmitters and Receivers, Integrated Insulin Pumps); Demographics (Child Population (?14 years), Adult Population (>14 years)); End User (Home Healthcare, ICUs, Diagnostic Centers, Clinics) and Geography

| Report Code: TIPRE00018031 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Continuous Glucose Monitoring Market 2028 By Component, Demographics, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Continuous Glucose Monitoring assists in tracking automatic blood glucose levels, sugar levels throughout day and night. The continuous glucose monitoring works by inserting a tiny sensor underneath skin especially under belly or arm. The sensor helps in measuring interstitial glucose levels in every few minutes and the information is transferred to monitor to display results. The continuous glucose management has a crucial role in diabetes management. Recently novel technology is utilized in continuous glucose monitoring devices for good efficiency and accurate results.

MARKET DYNAMICS

The key market drivers for Continuous Glucose Monitoring Market Includes, rising geriatric population across the globe along with increasing diabetes cases globally which demands for continuous blood sugar monitoring. Moreover, technological advancements in blood glucose level monitoring devices is expected to boost market growth during forecast period. However, lack of adequate reimbursement policies for devices is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Continuous Glucose Monitoring Market" is a specialized and in-depth study of the Medical Device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Continuous Glucose Monitoring market with detailed market segmentation by Components, demographics and end user. The Continuous Glucose Monitoring Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Continuous Glucose Monitoring Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Continuous Glucose Monitoring Market is segmented on the basis of components, demographics and end user. On the basis of component the market is segmented as, sensors, transmitters and receivers, integrated insulin pumps. On the basis of demographics the market is segmented as, child population and adult population. And on the basis of end user the market is segmented as, home healthcare, ICUs, diagnostic centers and clinics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Continuous Glucose Monitoring Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Continuous Glucose Monitoring Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Continuous Glucose Monitoring Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Continuous Glucose Monitoring Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Continuous Glucose Monitoring Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Continuous Glucose Monitoring Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Continuous Glucose Monitoring market in the global market. Below mentioned is the list of few companies engaged in the Continuous Glucose Monitoring Market.

The report also includes the profiles of key players in Continuous Glucose Monitoring Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Dexcom
  •   Menarini Diagnostics
  •   Echo Therapeutics, Inc.
  •   GlySens incorporated
  •   Johnson and Johnson
  •   Medtronic plc.
  •   Senseonics Holdings, Inc.
  •   F. Hofffmann-La Roche Ltd.
  •   Medtronic, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Continuous Glucose Monitoring Market - By Component
1.3.2 Continuous Glucose Monitoring Market - By Demographics
1.3.3 Continuous Glucose Monitoring Market - By End User
1.3.4 Continuous Glucose Monitoring Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CONTINUOUS GLUCOSE MONITORING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.3. EXPERT OPINIONS

5. CONTINUOUS GLUCOSE MONITORING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CONTINUOUS GLUCOSE MONITORING MARKET - GLOBAL MARKET ANALYSIS
6.1. CONTINUOUS GLUCOSE MONITORING - GLOBAL MARKET OVERVIEW
6.2. CONTINUOUS GLUCOSE MONITORING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. CONTINUOUS GLUCOSE MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - COMPONENT
7.1. OVERVIEW
7.2. COMPONENT MARKET FORECASTS AND ANALYSIS
7.3. SENSORS
7.3.1. Overview
7.3.2. Sensors Market Forecast and Analysis
7.4. TRANSMITTERS AND RECEIVERS
7.4.1. Overview
7.4.2. Transmitters and Receivers Market Forecast and Analysis
7.5. INTEGRATED INSULIN PUMPS
7.5.1. Overview
7.5.2. Integrated Insulin Pumps Market Forecast and Analysis
8. CONTINUOUS GLUCOSE MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - DEMOGRAPHICS
8.1. OVERVIEW
8.2. DEMOGRAPHICS MARKET FORECASTS AND ANALYSIS
8.3. CHILD POPULATION (?14 YEARS)
8.3.1. Overview
8.3.2. Child Population (?14 years) Market Forecast and Analysis
8.4. ADULT POPULATION (>14 YEARS)
8.4.1. Overview
8.4.2. Adult Population (>14 years) Market Forecast and Analysis
9. CONTINUOUS GLUCOSE MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOME HEALTHCARE
9.3.1. Overview
9.3.2. Home Healthcare Market Forecast and Analysis
9.4. ICUS
9.4.1. Overview
9.4.2. ICUs Market Forecast and Analysis
9.5. DIAGNOSTIC CENTERS
9.5.1. Overview
9.5.2. Diagnostic Centers Market Forecast and Analysis
9.6. CLINICS
9.6.1. Overview
9.6.2. Clinics Market Forecast and Analysis

10. CONTINUOUS GLUCOSE MONITORING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. CONTINUOUS GLUCOSE MONITORING MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DEXCOM
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MENARINI DIAGNOSTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ECHO THERAPEUTICS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLYSENS INCORPORATED
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MEDTRONIC PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SENSEONICS HOLDINGS, INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F. HOFFMANN-LA ROCHE LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDTRONIC, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Dexcom
3. Menarini Diagnostics
4. Echo Therapeutics, Inc.
5. GlySens Incorporated
6. Johnson and Johnson
7. Medtronic plc
8. Senseonics Holdings, Inc
9. F. Hoffmann-La Roche Ltd
10. Medtronic, Inc.
TIPRE00018031
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.